Sorafenib (Nexavar) is a new molecularly targeted therapy drug that can simultaneously exert dual effects on anti-angiogenesis and anti-tumor cell proliferation. In the past two years, sorafenib has received great attention in the treatment of liver cancer. Clinical research has made breakthrough progress. It can effectively prevent the progression of the disease and significantly extend the survival time of patients with advanced liver cancer. It has become a new and effective drug and treatment. method, creating a new era of targeted therapy for liver cancer.
https://www.medixocentre.com/sorafenib-cost
Like
Comment
Share
